FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891725196> ?p ?o ?g. }

• W2891725196 endingPage "e0203625" @default.
• W2891725196 startingPage "e0203625" @default.
• W2891725196 abstract "A growing body of evidence supports the role of platelets in cancer metastasis, escape from immune surveillance, and angiogenesis. Mean platelet volume (MPV), which reflects platelet turnover, is reported routinely as part of automated complete blood count. Accumulating evidence suggests that MPV is a useful biomarker in several diseases including cancer. However, its role in cancer patients receiving molecular targeted therapy has not been described in the literature.We retrospectively analysed the prognostic impact of MPV in advanced or recurrent EGFR mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitors (EGFR-TKIs). Lymphocyte-to-monocyte ratio (LMR) has been previously reported to be a poor prognostic factor in EGFR mutant non-small cell lung cancer and was also included as a covariate.Using the previously described Cutoff Finder algorithm, the cut-off points for MPV and LMR that best predicted progression free survival (PFS) of EGFR-TKI were determined as 10.3 and 2.8, respectively. The median PFS was 14.7 and 8.2 months in MPV low and high groups (p = 0.013, log-rank test). The median PFS was 13.5 and 6.2 months in LMR high and low groups (p < 0.001, log-rank test). MPV and LMR were independently distributed (chi square test) and the multivariate analysis using Cox's proportional hazards regression model revealed that high MPV, low LMR, and pleural effusion were significant predictors for shorter PFS.MPV and LMR, measured as part of routine complete blood count, can be utilized to predict the outcome of EGFR-TKI therapy with no additional costs. Our results suggest a mechanism of EGFR-TKI resistance which is associated with the functional status of the platelets." @default.
• W2891725196 created "2018-09-27" @default.
• W2891725196 creator A5010992819 @default.
• W2891725196 creator A5020847267 @default.
• W2891725196 creator A5033956905 @default.
• W2891725196 creator A5048207662 @default.
• W2891725196 creator A5049595318 @default.
• W2891725196 creator A5057803965 @default.
• W2891725196 creator A5060462446 @default.
• W2891725196 creator A5072515684 @default.
• W2891725196 date "2018-09-07" @default.
• W2891725196 modified "2023-10-07" @default.
• W2891725196 title "Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor" @default.
• W2891725196 cites W13788639 @default.
• W2891725196 cites W1656894086 @default.
• W2891725196 cites W1930662350 @default.
• W2891725196 cites W1969096316 @default.
• W2891725196 cites W1975741271 @default.
• W2891725196 cites W1988902102 @default.
• W2891725196 cites W2001309054 @default.
• W2891725196 cites W2018628280 @default.
• W2891725196 cites W2023902889 @default.
• W2891725196 cites W2028137929 @default.
• W2891725196 cites W2029587780 @default.
• W2891725196 cites W2066107570 @default.
• W2891725196 cites W2072671591 @default.
• W2891725196 cites W2096378972 @default.
• W2891725196 cites W2100373022 @default.
• W2891725196 cites W2118814167 @default.
• W2891725196 cites W2119351872 @default.
• W2891725196 cites W2119543049 @default.
• W2891725196 cites W2136404658 @default.
• W2891725196 cites W2136996876 @default.
• W2891725196 cites W2138600163 @default.
• W2891725196 cites W2140033718 @default.
• W2891725196 cites W2143674654 @default.
• W2891725196 cites W2169048611 @default.
• W2891725196 cites W2180481128 @default.
• W2891725196 cites W2348480799 @default.
• W2891725196 cites W2507334943 @default.
• W2891725196 cites W2562238960 @default.
• W2891725196 cites W2611950171 @default.
• W2891725196 doi "https://doi.org/10.1371/journal.pone.0203625" @default.
• W2891725196 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6128600" @default.
• W2891725196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30192878" @default.
• W2891725196 hasPublicationYear "2018" @default.
• W2891725196 type Work @default.
• W2891725196 sameAs 2891725196 @default.
• W2891725196 citedByCount "28" @default.
• W2891725196 countsByYear W28917251962019 @default.
• W2891725196 countsByYear W28917251962020 @default.
• W2891725196 countsByYear W28917251962021 @default.
• W2891725196 countsByYear W28917251962022 @default.
• W2891725196 countsByYear W28917251962023 @default.
• W2891725196 crossrefType "journal-article" @default.
• W2891725196 hasAuthorship W2891725196A5010992819 @default.
• W2891725196 hasAuthorship W2891725196A5020847267 @default.
• W2891725196 hasAuthorship W2891725196A5033956905 @default.
• W2891725196 hasAuthorship W2891725196A5048207662 @default.
• W2891725196 hasAuthorship W2891725196A5049595318 @default.
• W2891725196 hasAuthorship W2891725196A5057803965 @default.
• W2891725196 hasAuthorship W2891725196A5060462446 @default.
• W2891725196 hasAuthorship W2891725196A5072515684 @default.
• W2891725196 hasBestOaLocation W28917251961 @default.
• W2891725196 hasConcept C121608353 @default.
• W2891725196 hasConcept C126322002 @default.
• W2891725196 hasConcept C143998085 @default.
• W2891725196 hasConcept C190481736 @default.
• W2891725196 hasConcept C2776256026 @default.
• W2891725196 hasConcept C2776694085 @default.
• W2891725196 hasConcept C2780739268 @default.
• W2891725196 hasConcept C2781182431 @default.
• W2891725196 hasConcept C50382708 @default.
• W2891725196 hasConcept C66339696 @default.
• W2891725196 hasConcept C71924100 @default.
• W2891725196 hasConcept C89560881 @default.
• W2891725196 hasConcept C90924648 @default.
• W2891725196 hasConceptScore W2891725196C121608353 @default.
• W2891725196 hasConceptScore W2891725196C126322002 @default.
• W2891725196 hasConceptScore W2891725196C143998085 @default.
• W2891725196 hasConceptScore W2891725196C190481736 @default.
• W2891725196 hasConceptScore W2891725196C2776256026 @default.
• W2891725196 hasConceptScore W2891725196C2776694085 @default.
• W2891725196 hasConceptScore W2891725196C2780739268 @default.
• W2891725196 hasConceptScore W2891725196C2781182431 @default.
• W2891725196 hasConceptScore W2891725196C50382708 @default.
• W2891725196 hasConceptScore W2891725196C66339696 @default.
• W2891725196 hasConceptScore W2891725196C71924100 @default.
• W2891725196 hasConceptScore W2891725196C89560881 @default.
• W2891725196 hasConceptScore W2891725196C90924648 @default.
• W2891725196 hasIssue "9" @default.
• W2891725196 hasLocation W28917251961 @default.
• W2891725196 hasLocation W28917251962 @default.
• W2891725196 hasLocation W28917251963 @default.
• W2891725196 hasLocation W28917251964 @default.
• W2891725196 hasLocation W28917251965 @default.
• W2891725196 hasOpenAccess W2891725196 @default.
• W2891725196 hasPrimaryLocation W28917251961 @default.

• next